Financials 4Front Ventures Corp.

Equities

FFNT

CA35086B2075

Healthcare Facilities & Services

Market Closed - Canadian Securities Exchange 20:59:44 19/07/2024 BST 5-day change 1st Jan Change
0.13 CAD -10.34% Intraday chart for 4Front Ventures Corp. -7.14% 0.00%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization 1 243 402.2 596.8 146.8 65.65 86.64
Enterprise Value (EV) 1 243 402.2 596.8 146.8 65.65 86.64
P/E ratio - - - - - -
Yield - - - - - -
Capitalization / Revenue 7.81 x 4.57 x 5.71 x 1.24 x 0.67 x 0.98 x
EV / Revenue 7.81 x 4.57 x 5.71 x 1.24 x 0.67 x 0.98 x
EV / EBITDA -11.6 x 68.2 x 17.6 x 5.3 x 6.53 x 5.3 x
EV / FCF - - - -8.06 x -12.6 x -4.12 x
FCF Yield - - - -12.4% -7.92% -24.3%
Price to Book - - - - - -
Nbr of stocks (in thousands) 535,303 445,472 594,126 642,137 669,519 915,200
Reference price 2 0.5900 1.150 1.270 0.3100 0.1300 0.1300
Announcement Date 15/06/20 06/04/21 30/03/22 30/03/23 15/04/24 -
1CAD in Million2
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales 1 31.13 88.1 104.6 118.6 97.44 88.7
EBITDA 1 -20.93 5.9 34 27.7 10.06 16.36
EBIT - - - -26.99 -20.64 -
Operating Margin - - - -22.76% -21.18% -
Earnings before Tax (EBT) - - - - - -
Net income - - - - - -
Net margin - - - - - -
EPS - - - - - -
Free Cash Flow 1 - - - -18.21 -5.197 -21.03
FCF margin - - - -15.36% -5.33% -23.71%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 15/06/20 06/04/21 30/03/22 30/03/23 15/04/24 -
1USD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales 28.53 26.05 28.44 32.47 31.62 30.38 30.7 23 -
EBITDA 1 13.2 9.018 9.2 9.311 0.2 3.515 1.987 3.5 2.5
EBIT - - - 0.517 -22.17 - - - -
Operating Margin - - - 1.59% -70.12% - - - -
Earnings before Tax (EBT) - - - - - - - - -
Net income - - - - - - - - -
Net margin - - - - - - - - -
EPS - - - - - - - - -
Dividend per Share - - - - - - - - -
Announcement Date 30/03/22 23/05/22 15/08/22 14/11/22 30/03/23 15/05/23 15/08/23 20/11/23 15/04/24
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - - -18.2 -5.2 -21
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex 1 - - - 27 3.36 53.3
Capex / Sales - - - 22.75% 3.45% 60.09%
Announcement Date 15/06/20 06/04/21 30/03/22 30/03/23 15/04/24 -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.0947 USD
Average target price
0.11 USD
Spread / Average Target
+16.19%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. FFNT Stock
  4. Financials 4Front Ventures Corp.